Bruce L. A. Carter
Chief Executive Officer, ZYMOGENETICS INC.
Companies
- ENANTA PHARMACEUTICALS INCBoard member Dec 6, 2013 to now1
- Mirati Therapeutics, Inc.Board member Sep 29, 2016 to Jan 23, 20242
- ALSP Orchid Acquisition Corp IBoard member Nov 18, 2021 to Nov 18, 20213
- Xencor IncBoard member Dec 2, 2013 to Jun 16, 20174
- Regulus Therapeutics Inc.Board member Oct 4, 2012 to Jun 26, 20155
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ENANTA PHARMACEUTICALS INC ENTA0 shares6Mar 21, 2022
- Mirati Therapeutics, Inc.0 shares7Jan 23, 2024
- ALSP Orchid Acquisition Corp I0 shares8Nov 18, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 23, 2024Returned to company 6,808 shares of Mirati Therapeutics, Inc.7
- Jan 23, 2024Returned to company 4,444 shares of Mirati Therapeutics, Inc.7
- Jan 23, 2024Returned to company 6,021 shares of Mirati Therapeutics, Inc.7
- Dec 29, 2023Granted 6,808 shares at $58.75 of Mirati Therapeutics, Inc.9
- Jan 20, 2023Granted 4,444 shares of Mirati Therapeutics, Inc.10
- Aug 12, 2022Sold 4,893 shares at $85.96 of Mirati Therapeutics, Inc.11
- Aug 12, 2022Sold 5,107 shares at $85.04 of Mirati Therapeutics, Inc.11
- Aug 12, 2022Exercised options 10,000 shares at $27.00 of Mirati Therapeutics, Inc.11
- Mar 21, 2022Sold 807 shares at $69.52 of ENANTA PHARMACEUTICALS INC6
- Mar 21, 2022Sold 2,210 shares at $68.66 of ENANTA PHARMACEUTICALS INC6
- Mar 21, 2022Sold 307 shares at $67.23 of ENANTA PHARMACEUTICALS INC6
- Mar 21, 2022Sold 2,676 shares at $66.70 of ENANTA PHARMACEUTICALS INC6
- Mar 21, 2022Exercised options 6,000 shares at $25.58 of ENANTA PHARMACEUTICALS INC6
- Jan 14, 2022Granted 2,546 shares of Mirati Therapeutics, Inc.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARXencor Inc, Board member
- 5
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Jan 3, 2024
- 10SEC EDGARForm 4 filed Jan 24, 2023
- 11SEC EDGARForm 4 filed Aug 16, 2022
- 12SEC EDGARForm 4 filed Jan 18, 2022